促销时间表 Sanofi India Limited
先进的时间表
简单图表
关于公司 Sanofi India Limited
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, central nervous system, anti-infectives, epilepsy, allergy and vitamins, and minerals and supplements, as well as pain care and nutritional health under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Glimepiride, Cetapin, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. 更多详情| ISIN | INE058A01010 |
|---|---|
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | inr |
| Валюта отчета | inr |
| Див.доход ао | 1.71 |
| Дивиденд ао | 68.21 |
| Сайт | https://www.sanofiindialtd.com |
| Цена ао | 5991.15 |
| 每日价格变化: | -2.67% (5991.15) |
|---|---|
| 每周价格变化: | +2.25% (5702.95) |
| 每月价格变化: | +15.25% (5059.65) |
| 3个月内价格变化: | -4.34% (6095.85) |
| 六个月内的价格变化: | -13.79% (6764.2) |
| 每年价格变化: | -28.17% (8118.25) |
| 3年内价格变化: | -20.58% (7341.85) |
| 5年内价格变化: | -20.85% (7367.55) |
| 年初以来价格变化: | -5.23% (6152.95) |
|
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
|||||||||||||||||||||||||||||||||||||
| ETF | 分享, % | 本年盈利能力, % | 股息, % |
|---|---|---|---|
| iShares MSCI India Small-Cap ETF | 0.16695 | 0.4625 | 0.96163 |
| SPDR S&P Emerging Markets Small Cap ETF | 0.07114 | 5.46 | 3.03583 |
| iShares MSCI Emerging Markets Small-Cap ETF | 0.04483 | 7.67 | 2.7853 |
| Avantis Emerging Markets Value ETF | 0.03441 | 14.12 | 4.22231 |
| Avantis Responsible Emerging Markets Equity ETF | 0.02777 | 17.6 | 3.1719 |
Vanguard FTSE All-World ex-US Small-Cap ETF
|
0.02 | 9.39 | 3.09932 |
| Avantis Emerging Markets Equity ETF | 0.01484 | 8.77 | 3.60513 |
| Dimensional Emerging Markets Core Equity 2 ETF | 0.0079 | 15.96 | 3.34087 |
| Dimensional World ex U.S. Core Equity 2 ETF | 0.00469 | 13.06 | 3.62488 |
| FlexShares Morningstar Emerging Markets Factor Tilt Index Fund | 0.00447 | 12.46 | 3.59676 |
| 0.04 | 10.5 | 3.15 |
| 导师 | 职称 | 支付 | 出生年份 |
|---|---|---|---|
| Mr. Rodolfo Hrosz | MD & Director | 17.85M | 1967 (58 年) |
| Mr. M. K. Narayanaswamy B.Com.,A.I.C.W.A. | Senior Director of Accounting & Taxation | N/A | 1955 (70 年) |
| Mr. Sanjay V. Chavan | Head of Country Procurement - India | N/A | 1962 (63 年) |
| Ms. Surabhi Kaur | People & Culture Director | N/A | |
| Ms. Renee Amonkar | Additional Whole Time Director | N/A | |
| Mr. Rachid Ayari | CFO & Whole Time Director | N/A | |
| Ms. Flovie Martins | Head of Corporate Communications & Corporate Social Responsibility | ||
| Nakul Verma | Senior Director of Public Affairs | ||
| Yasmin Shenoy | Senior Director of Regulatory Affairs | ||
| Mr. N. Suresh Babu | Sales & Customer Engagement Head - Diabetes and Senior Director of Diabetes |
